Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial Agents

Papireddy Kancharla, Diana Ortiz, Corinne M. Fargo, Xiaowei Zhang, Yuexin Li, Marco A. Sánchez, Amrendra Kumar, Monish Yeluguri, Rozalia A. Dodean, Diana Caridha, Michael S. Madejczyk, Monica Martin, Xiannu Jin, Cameron Blount, Ravi Chetree, Kristina Pannone, Hieu Dinh, Jesse DeLuca, Martin Evans, Robert J. Nadeau, Chau Vuong, Susan E. Leed, William E. Dennis, Norma Roncal, Brandon Pybus, Patricia Lee, Alison Roth, Kevin A. Reynolds, Jane X. Kelly, Scott M. LandfearJournal of Medicinal Chemistry 2024 · DOI

Abstract

Leishmaniasis is a neglected tropical disease that is estimated to afflict over 12 million people. Current drugs for leishmaniasis suffer from serious deficiencies, including toxicity, high cost, modest efficacy, primarily parenteral delivery, and emergence of widespread resistance. We have discovered and developed a natural product-inspired tambjamine chemotype, known to be effective against <i>Plasmodium</i> spp, as a novel class of antileishmanial agents. Herein, we report in vitro and in vivo antileishmanial activities, detailed structure-activity relationships, and metabolic/pharmacokinetic profiles of a large library of tambjamines. A number of tambjamines exhibited excellent potency against both <i>Leishmania mexicana</i> and <i>Leishmania donovani</i> parasites with good safety and metabolic profiles. Notably, tambjamine <b>110</b> offered excellent potency and provided partial protection to leishmania-infected mice at 40 and/or 60 mg/kg/10 days of oral treatment. This study presents the first account of antileishmanial activity in the tambjamine family and paves the way for the generation of new oral antileishmanial drugs.
BibTeX
@article{kancharla2024discovery,
  author = {Papireddy Kancharla and Diana Ortiz and Corinne M. Fargo and Xiaowei Zhang and Yuexin Li and Marco A. Sánchez and Amrendra Kumar and Monish Yeluguri and Rozalia A. Dodean and Diana Caridha and Michael S. Madejczyk and Monica Martin and Xiannu Jin and Cameron Blount and Ravi Chetree and Kristina Pannone and Hieu Dinh and Jesse DeLuca and Martin Evans and Robert J. Nadeau and Chau Vuong and Susan E. Leed and William E. Dennis and Norma Roncal and Brandon Pybus and Patricia Lee and Alison Roth and Kevin A. Reynolds and Jane X. Kelly and Scott M. Landfear},
  title = {{Discovery and Optimization of Tambjamines as a Novel Class of Antileishmanial Agents}},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00517},
}

Loading related content...

Figure